Psychedelic

The Magic Mushrooms and MDMA market is hitting new milestones. Canada has licensed Optimi Health Corp. (OTC:OPTHF) to export psilocybin and MDMA to Australia, marking a significant step in the medical psychedelic drugs market. This license allows the Vancouver-based startup to ship controlled...

Courtney Barnes, a partner at Feldman Legal Advisors, advocate for psychedelic policy reform and upcoming guest at the Benzinga Cannabis Capital Conference positioned herself at the front lines of the legal landscape for cannabis and psychedelics, steering the conversation around regulation and...

Recent advancements within the field of mental health with the use of psilocybin-assisted therapy, as well as Colorado’s forward-thinking legislation about this therapy, have proven exciting. Psilocybin-assisted therapy showcased promising results in treating Generalized Anxiety Disorder (GAD...

In August, a group of well-known biotech institutional investors participated in an up to almost $300 million financing round for COMPASS Pathways (NASDAQ: CMPS), consisting of an initial investment of $125 million and the potential for an additional investment of up to $160 million if the...

Tesla CEO and Twitter Owner Elon Musk took a dig at Apple's new $3,500 augmented reality headset on Thursday. What Happened: Musk put out a meme on Twitter that featured a woman wearing the Vision Pro headset and some mushrooms that can "chemically" change your "carbon vibrations." The mushrooms...

Elon Musk shared his take on Adderall, a medication that is used to treat attention deficit hyperactivity disorder, or ADHD, on Sunday. What Happened: Musk said in response to a post on Twitter, "Adderall is an anger amplifier. Best used sparingly or not at all." Adderall is an anger amplifier....

The people of the future may not have to do much to get high or indeed have to pay through their noses to do so provided Twitter owner Elon Musk is correct. What Happened: Musk interacted with writer and illustrator Tim Urban on Twitter. Urban said the people of the future will simply go to an app...

Cannabis is a psychedelic that belongs to the group of mind-manifesting substances, according to Dr. Julie Holland. "When you get high on cannabis, you can see your thoughts differently, and it can give you a bigger perspective on life," she said in an interview with Rena Sherbill...

By Santiago Federico Richetti via El Planteo Reviewed by Dr. Bruno Rasmussen Chaves Ibogaine is a substance extracted from the root of the iboga, a shrub that grows in West Africa. For thousands of years, it has been used by indigenous cultures for healing rituals. Since the sixties of the last...

Clinical-stage developer of psychedelic compounds Tryp Therapeutics Inc. (OTCQB: TRYPF) filed two provisional patent applications - one for psilocybin therapy for fibromyalgia and another expanding psilocybin-based TRP-8803 development’s IP.   Tryp's Psilocybin-For-...

Whether you're into finances or just a fan of Shark Tank, chances are you know who Kevin O’Leary is. AKA Mr. Wonderful, the Canadian investor of Irish heritage is well known in the finance space and as a TV personality.  But, who is the real ...

PSYC Corporation (OTC: PSYC) a psychedelic news and information platform, has announced that the company incorporated Spotlight Media Corporation, its wholly owned subsidiary. PSYC said that the move resulted from the intent of more effectively positioning the company to expand on its existing...

Rep. Tony Lovasco (R) from Missouri filed a bill on Tuesday that would legalize the use of psychedelics for therapeutic use at designated care facilities and decriminalize low-level possession, reported Marijuana Moment. The bill would provide patients with certain serious conditions like treatment...

PSYC Corporation, formerly known as Global Trac Solutions, Inc. (OTCPK: PSYC) and the company behind psychedelic news and information platform Psychedelic Spotlight, completed the process of changing its corporate name from Global Trac Solutions, Inc. to PSYC Corporation. The company will continue...

Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced Tuesday that Robert Barrow has been appointed CEO and member of the board of directors. Barrow, an accomplished pharmaceutical executive and a recognized leader in the psychedelic industry, is...